Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 November 2005

Intellectual Property 101

George B. Stefano, J. Patrick Finn III

Med Sci Monit 2005; 11(11): ED7-7 :: ID: 430274

Abstract

Sometimes what we don’t know really can hurt us. After many discussions with colleagues around the world, Medical Science Monitor will start to carry information, which may help us realize the significance of intellectual property and how we may protect it. This information, which is general in nature given our global audience, may vary in its interpretation and implementation, depending on your country. However, it will cause us all to think about the signifi cance of what we are doing in advancing knowledge by being creative.
Regardless of what country you are in, there is a mechanism to protect intellectual property. In general, intellectual property can be defi ned as any useful technology, e.g., a drug or treatment protocol that you invented that is novel and not obvious. Note, a potential inventor should keep information relating to the intellectual property confi dential since making it public can result in a loss of potential intellectual property rights. This means that in order to protect your intellectual property you should avoid disclosing it to others both orally and in writing before it is protected. The exceptions to this rule are that you may discuss it with your employer (e.g., a university/ company/hospital offi cial), any co-inventors, and your or your employer’s lawyer. It is important to remember that any public disclosure without, for example, fi ling a patent application can result in giving away the technology.
If you plan to discuss this technology with an interested party, a confi dentiality agreement should
be in place whereby the party agrees not to use your technology except for purposes of evaluation and agrees to keep it confi dential. One major consideration regarding new intellectual property is whether the technology is important. Does it have the potential to generate revenue for its owners or provide signifi cant help to others? Many technologies are patentable (e.g., novel and non-obvious), but few generate a revenue stream. It is important to have discussions with experts that can help you make this determination. In some cases, individuals can lose the ability to obtain protection by publishing their work without even realizing that their publication discloses new intellectual property that may have monetary advantages. In other words, an individual may lose the ability to obtain patent protection simply by not communicating the technology to the appropriate experts.To help provide researchers and clinicians with valuable intellectual property information, Index Copernicus can be used to determine what types of intellectual properties exist, e.g., patents. Index Copernicus also can be used to find legal mechanisms for obtaining protection and experts who may assist in rendering legal advice regarding your technology. If you don’t know what you have – you don’t have it. Dr. Stefano is Vice Chair of the Board of Directors of the Research Foundation of the State University of New York and member of the State University of New York Patent Committee. J. Patrick Finn III, Ph.D, J.D. is a patent attorney at Fish & Richardson, P.C. and contributed to this article. One focus of his practice is obtaining world-wide patent protection for universities as well as biotech and medical device clients.

Keywords: Intellectual Property, Information Services, Biotechnology, Patents as Topic

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750